Cytokinetics Inc. buy Royal Bank of Canada
Start price
18.12.24
/
50%
€45.80
Target price
18.12.25
€78.17
Performance (%)
14.63%
End price
19.12.25
€52.50
Summary
This prediction ended on 19.12.25 with a price of €52.50. The prediction had a final performance of 14.63%. Royal_Bank_of_Canada has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | 1.342% | 1.342% | 123.270% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target raised by analysts at Royal Bank of Canada from $80.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€55.50
11.11.25
11.11.25
€75.30
11.11.26
11.11.26
27.93%
24.07.26
24.07.26
Stopped prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€57.50
20.02.26
20.02.26
€85.91
20.02.27
20.02.27
23.48%
24.07.26
24.07.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€54.00
21.01.26
21.01.26
€81.00
21.01.27
21.01.27
31.48%
24.07.26
24.07.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.40
07.05.25
07.05.25
€70.52
07.05.26
07.05.26
112.86%
08.05.26
08.05.26